NCT00061503View on ClinicalTrials.gov

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost

Trial Locations (1)

Unknown

Alcon Call Center, Call For Details

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00061503 - Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter